Company & Sponsor Intelligence
Wyeth is now a wholly owned subsidiary of Pfizer
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials1
Recruiting0
Completed1
Countries1
Therapeutic footprint
alzheimers
Indexed studies
NCT00745576Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered
alzheimers · FrancePHASE1
alzheimers · FrancePHASE1
NCT00151333Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)
alzheimers · United StatesPHASE2
alzheimers · United StatesPHASE2
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →